ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,277.51
      0.80%
      US Tech 100
      18,064.80
      0.02%
      Dow Jones
      38,686.32
      1.51%
      Brent Oil
      81.295
      0.00%
      Bitcoin
      68,185.51
      0.68%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Finch Therapeutics Group Inc (FNCH)

      7. Finch Therapeutics Group Inc (FNCH) News

      FNCH

      Finch Therapeutics (FNCH)

      Finch Therapeutics Group Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:FNCH
      DateTimeSourceHeadlineSymbolCompany
      05/24/20246:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FNCHFinch Therapeutics Group Inc
      05/17/20244:45PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FNCHFinch Therapeutics Group Inc
      05/10/20244:45PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FNCHFinch Therapeutics Group Inc
      02/23/20244:12PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FNCHFinch Therapeutics Group Inc
      12/13/20235:20PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:FNCHFinch Therapeutics Group Inc
      11/17/20234:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FNCHFinch Therapeutics Group Inc
      11/08/20236:30AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FNCHFinch Therapeutics Group Inc
      08/11/20236:31AMEdgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:FNCHFinch Therapeutics Group Inc
      08/10/20236:31AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FNCHFinch Therapeutics Group Inc
      07/07/20234:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FNCHFinch Therapeutics Group Inc
      06/28/20234:31PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FNCHFinch Therapeutics Group Inc
      06/28/20234:31PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FNCHFinch Therapeutics Group Inc
      06/23/20234:31PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:FNCHFinch Therapeutics Group Inc
      06/09/20235:01PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FNCHFinch Therapeutics Group Inc
      06/09/20234:53PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FNCHFinch Therapeutics Group Inc
      06/09/20234:23PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FNCHFinch Therapeutics Group Inc
      06/09/20234:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FNCHFinch Therapeutics Group Inc
      06/09/20234:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FNCHFinch Therapeutics Group Inc
      06/09/20234:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FNCHFinch Therapeutics Group Inc
      06/09/20237:00AMGlobeNewswire Inc.Finch Announces Reverse Stock Split of Common StockNASDAQ:FNCHFinch Therapeutics Group Inc
      05/30/20234:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FNCHFinch Therapeutics Group Inc
      05/18/20234:15PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FNCHFinch Therapeutics Group Inc
      05/16/20234:17PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:FNCHFinch Therapeutics Group Inc
      05/11/20234:13PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:FNCHFinch Therapeutics Group Inc
      05/11/20234:05PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FNCHFinch Therapeutics Group Inc
      05/10/20237:15AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:FNCHFinch Therapeutics Group Inc
      05/10/20237:13AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FNCHFinch Therapeutics Group Inc
      05/10/20237:00AMGlobeNewswire Inc.Finch Therapeutics Reports First Quarter 2023 Financial Results and Provides Business UpdatesNASDAQ:FNCHFinch Therapeutics Group Inc
      04/26/20234:05PMEdgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:FNCHFinch Therapeutics Group Inc
      04/26/20234:03PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:FNCHFinch Therapeutics Group Inc
       Showing the most relevant articles for your search:NASDAQ:FNCH

      Your Recent History

      EU
      FRSG00014BX1
      SG Issuer Med Term Nts S...
      BMF
      MR1F25N25
      MR1F25N25 - 01/2025
      Delayed Upgrade Clock